Abstract:Insulin-like growth factor 2 messenger RNA-binding proteins have been described to associate with malignant process in many cancers. However, the role of insulin-like growth factor 2 messenger RNA-binding protein family has not been thoroughly elucidated in non–small cell lung cancer. This study was to investigate the expression profile, clinical significance, and biological function of insulin-like growth factor 2 messenger RNA-binding proteins family in non–small cell lung cancer. The expression levels of IGF2BP1–IGF2BP3 in tumor and adjacent normal tissues were determined, and association with clinicopathological features and overall survival was investigated by analyzing The Cancer Genome Atlas lung cancer database. Proliferation, migration, invasion assays, and flow-cytometry analysis were used to investigate the biological function in vitro. Insulin-like growth factor 2 messenger RNA-binding protein expression levels were significantly increased in non–small cell lung cancer compared to adjacent normal lung tissues. Chi-square test indicated that IGF2BP1 and IGF2BP3 expressions correlated with some meaningful clinical characteristics in non–small cell lung cancer. Kaplan–Meier analysis showed that high-level expression of IGF2BP1 or IGF2BP3 predicted poor overall survival in lung adenocarcinoma patients. Multivariate regression analysis showed that high level of IGF2BP3 was an independent risk factor for poor prognosis in lung adenocarcinoma patients (hazard ratio = 1.616, p = 0.017). In vitro, knockdown of IGF2BP3 inhibited lung adenocarcinoma cell proliferation by inducing cell cycle arrest and apoptosis, and undermined abilities of migration and invasion, and overexpression of IGF2BP3 could promote malignant phenotypes in lung adenocarcinoma cells. Our study revealed that expression of insulin-like growth factor 2 messenger RNA-binding proteins was widely upregulated and correlated with some certain clinicopathological features in non–small cell lung cancer. Especially, in insulin-like growth factor 2 messenger RNA-binding protein family, IGF2BP3 might play the most important role in tumor aggressiveness and prognosis in lung adenocarcinoma, and IGF2BP3 might serve as a potential therapeutic target and a novel prognostic biomarker in lung adenocarcinoma patients.

Targeting insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs) for the treatment of cancer

The Oncogenic Functions of Insulin-like Growth Factor 2 mRNA-Binding Protein 3 in Human Carcinomas

Targeting IGF2BP3 in Cancer

IGF2BPs As Novel M6a Readers: Diverse Roles in Regulating Cancer Cell Biological Functions, Hypoxia Adaptation, Metabolism, and Immunosuppressive Tumor Microenvironment

Igfbp, A Novel Target of Lung Cancer?

The role of circular RNA targeting IGF2BPs in cancer-a potential target for cancer therapy

A Pan-Cancer Landscape of IGF2BPs and Their Association with Prognosis, Stemness and Tumor Immune Microenvironment.

The Role of IGF2BP2, an M6a Reader Gene, in Human Metabolic Diseases and Cancers

Pan-cancer analysis identified IGF2BP2 as a potential prognostic biomarker for multiple tumor types

Advances in Targeting Insulin-Like Growth Factor Signaling Pathway in Cancer Treatment.

Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors in cancer therapy: advances and perspectives.

A Pan-Cancer Analysis of the Oncogenic Role of Insulin-Like Growth Factor2 mRNA -Binding Protein 2 (IGF2BP2) in Human Tumors

Up-regulation of IGF2BP2 by multiple mechanisms in pancreatic cancer promotes cancer proliferation by activating the PI3K/Akt signaling pathway

Insulin-like Growth Factor 2 Mrna-Binding Protein 2 is a Therapeutic Target in Ovarian Cancer.

Insulin-like growth factor binding protein-related protein 1 and cancer.

RNA-binding protein IGF2BP2 suppresses metastasis of clear cell renal cell carcinoma by enhancing CKB mRNA stability and expression

N 6 -methyladenosine modification of RIMS binding protein 2 promotes head and neck squamous cell carcinoma proliferation and radiotherapy tolerance through endoplasmic reticulum stress

Expression Profile, Clinical Significance, and Biological Function of Insulin-Like Growth Factor 2 Messenger RNA-binding Proteins in Non–small Cell Lung Cancer

Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in hematological diseases

Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy

IGF2BP2 promotes head and neck squamous carcinoma cell proliferation and growth via the miR-98-5p/PI3K/Akt signaling pathway